drugset / Trial / NCT00032942
Lofexidine for Opiate Withdrawal - 1
Phase 3
Completed
66 enrolled
National Institute on Drug Abuse (NIDA)
Britannia Pharmaceuticals Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate lofexidine for opiate withdrawal.
Timeline
- Start
- 2001-04
- Primary completion
- 2004-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lofexidine | Small molecule | — | — |